Splinterlands and Rad Intelligence to Work Together to Expand Global Guild/Scholar Program
Philadelphia, Pennsylvania–(Newsfile Corp. – April 28, 2022) – Splinterlands today announced that it will work…
Philadelphia, Pennsylvania–(Newsfile Corp. – April 28, 2022) – Splinterlands today announced that it will work…
The hyper deflationary coin was created to make a positive impact on the world by…
Los Angeles, California–(Newsfile Corp. – April 28, 2022) – SOLIS is excited to announce its…
Utility generates incremental revenue stream by providing billing data to the neighboring utility operated by…
The acquisition further strengthens the Vancouver media company’s technology solutions and monetization capabilities VANCOUVER, British…
PALO ALTO, Calif.–(BUSINESS WIRE)–ShangBay Capital, a venture capital firm focused on investing in healthcare companies,…
SAN FRANCISCO–(BUSINESS WIRE)–Arable and Bayer announced today a partnership to accelerate digital transformation in agriculture…
Improved net result and US operations profitable Strengthened investments for innovation Cash runway over 24…
— President is New Position for the Young, Growing Airline; Current CPO & General Counsel…
TYSONS, Va.–(BUSINESS WIRE)–TEGNA Inc.’s (NYSE: TGNA) Board of Directors declared a regular quarterly dividend of…
ORION CORPORATION INTERIM REPORT 1–3/2022 28 APRIL 2022 at 16:00 EEST CORRECTION: Orion Group Interim Report 1–3/2022 This…
SAN DIEGO and PALO ALTO, Calif., April 28, 2022 (GLOBE NEWSWIRE) — Scilex Holding Company…
ANSM approves NATRUNIX for INSA funded Phase-I-III Study at 20 Leading Medical Centers in France…
TORONTO, April 28, 2022 (GLOBE NEWSWIRE) — Mountain Valley MD Holdings Inc. (the “Company” or…
LONDON and PHOENIX, April 28, 2022 (GLOBE NEWSWIRE) — AccuStem Sciences, Inc. (OTCQB: ACUT), a…
FREMONT, CA, April 28, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – ABVC Biopharma, Inc. (NASDAQ:…
New Position Aimed at Attracting, Retaining, and Cultivating a Best-in-Class Workforce as Allogene Scales its…
BOSTON, April 28, 2022 (GLOBE NEWSWIRE) — AVEO Oncology (Nasdaq: AVEO), a commercial stage, oncology-focused biopharmaceutical…
Follow up ILUVIEN® PALADIN data to be presented onsite at the annual Association for Research…
LEXINGTON, Mass., April 28, 2022 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the…